← Leaderboards
George Mitra
Leidos Biomedical Research, Inc.
$28,582,538
Attributed
$28,582,538
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $8.3M · FY2018–25$10M$7.5M$5M$2.5M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,582,538 · 2
By mechanism
N01$28,582,538 · 2
Top collaborators
No co-investigators on record.
Most similar at Leidos Biomedical Research, Inc.
Same institution · by research overlap
- David Heimbrook$2,362,140,846
- Leonard Freedman$1,216,107,431
- Lynn Briscoe$495,968,635
- Ethan Dmitrovsky$597,515,186
- David Lindsay$51,337,878
Others in their field
Other Emerging Leaders on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$211,662,224
Research focus
BaseVectorManufacturing ProcessClinical DevelopmentClinical LotClinical ResearchClinical TrialsTechnologyFreedomRare DiseasesGenesGene TherapyGene Therapy TrialPre-ClinicalManufacturing Process DevelopmentChemistryTechnology DevelopmentMethylmalonic AciduriaNational Center For Advancing Translational SciencesManufactureMulti-Institutional Clinical TrialAnticancer ResearchOperationLaboratories
Grant awards (8)
CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS$4,493,105
N01 · FY2025 · CA · contact PI
CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS$5,077,161
N01 · FY2024 · CA · contact PI
CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS$1,777,461
N01 · FY2023 · CA · contact PI
CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS$1,699,083
N01 · FY2022 · CA · contact PI
CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS$7,268,296
N01 · FY2021 · CA · contact PI
GD2 CAR T MANUFACTURING$4,696,754
N01 · FY2019 · CA · contact PI
CMC SUPPORT FOR NCATS RARE DISEASE PLATFORM GENE THERAPY TRIAL PROJECTS$3,561,763
N01 · FY2019 · CA · contact PI
IGF::OT::IGF NS IDIQ: OPERATIONS AND TECHNICAL SUPPORT (OTS) FOR THE FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH (FNLCR), A FEDERALLY FUNDED RESEARCH AND DEVELOPMENT CENTER (FFRDC)$8,915
N01 · FY2018 · CA · contact PI